Search results for "Pathophysiology of hypertension"

showing 10 items of 15 documents

Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease

2016

AbstractWe have reviewed the effects of angiotensin II type 1 receptor antagonists (ARBs) in various animal models of hypertension, atherosclerosis, cardiac function, hypertrophy and fibrosis, glucose and lipid metabolism, and renal function and morphology. Those of azilsartan and telmisartan have been included comprehensively whereas those of other ARBs have been included systematically but without intention of completeness. ARBs as a class lower blood pressure in established hypertension and prevent hypertension development in all applicable animal models except those with a markedly suppressed renin–angiotensin system; blood pressure lowering even persists for a considerable time after d…

0301 basic medicineBlood Pressure030204 cardiovascular system & hematologyKidneyurologic and male genital diseasesBenzoatesAnimals Genetically ModifiedRenin-Angiotensin SystemGene Knockout Techniques0302 clinical medicineAzilsartanPharmacology (medical)TelmisartanOxadiazolesKidneybiologyStrokemedicine.anatomical_structureCardiovascular DiseasesHypertensionDrug Therapy Combinationmedicine.drugmedicine.medical_specialty03 medical and health sciencesMetabolic DiseasesCulture TechniquesInternal medicineRenin–angiotensin systemmedicineAnimalsHumansAntihypertensive AgentsPharmacologyAngiotensin II receptor type 1business.industryAngiotensin-converting enzymeAtherosclerosisLipid Metabolismmedicine.diseaseDisease Models AnimalGlucose030104 developmental biologyBlood pressureEndocrinologyPathophysiology of hypertensionbiology.proteinBenzimidazolesEndothelium VascularTelmisartanbusinessAngiotensin II Type 1 Receptor BlockersPharmacology & Therapeutics
researchProduct

Reconstitution of Myelomonocyte-Depleted Mice With Monocytes, But Not With Neutrophils, Reestablishes Arterial Hypertension and Oxidative Stress in R…

2011

0303 health sciencesmedicine.medical_specialty030309 nutrition & dieteticsbusiness.industry030302 biochemistry & molecular biologymedicine.disease_causemedicine.diseaseBiochemistry03 medical and health sciencesEndocrinologyPhysiology (medical)Pathophysiology of hypertensionInternal medicinemedicinebusinessMyelomonocyteOxidative stressFree Radical Biology and Medicine
researchProduct

SYMPATHETIC NERVOUS SYSTEM AND BLOOD-PRESSURE CONTROL IN ESSENTIAL HYPERTENSION

1978

Abstract In normotensive subjects an inverse correlation was observed between an index of sympathetic nervous activity (the plasma-noradrenaline concentration during physical exercise) and reactivity to exogenous noradrenaline. This relationship was invariably disturbed in age-matched patients with essential hypertension. Multiple-regression analysis revealed a highly significant correlation between the combination of both factors and the height of mean arterial blood-pressure ( r =0·91). The findings suggest that sympathetic nervous activity and pressor response to noradrenaline together form an important determinant of the arterial blood-pressure level. An inverse relationship could be de…

AdultMaleBlood pressure controlmedicine.medical_specialtySympathetic nervous systemSympathetic Nervous SystemRestPhysical ExertionBlood PressurePhysical exerciseEssential hypertensionNorepinephrineInternal medicineReninHumansMedicineInverse correlationbusiness.industryAngiotensin IIGeneral MedicineMiddle Agedmedicine.diseaseAngiotensin IIHormonesmedicine.anatomical_structureEndocrinologyPressor responsePathophysiology of hypertensionHypertensionRegression AnalysisFemalebusinessThe Lancet
researchProduct

Platelet-localized FXI promotes a vascular coagulation-inflammatory circuit in arterial hypertension

2017

Multicellular interactions of platelets, leukocytes, and the blood vessel wall support coagulation and precipitate arterial and venous thrombosis. High levels of angiotensin II cause arterial hypertension by a complex vascular inflammatory pathway that requires leukocyte recruitment and reactive oxygen species production and is followed by vascular dysfunction. We delineate a previously undescribed, proinflammatory coagulation-vascular circuit that is a major regulator of vascular tone, blood pressure, and endothelial function. In mice with angiotensin II-induced hypertension, tissue factor was up-regulated, as was thrombin-dependent endothelial cell vascular cellular adhesion molecule 1 ex…

Blood PlateletsMale0301 basic medicinemedicine.medical_specialtyMacrophage-1 AntigenVascular Cell Adhesion Molecule-1Blood Pressure030204 cardiovascular system & hematologyThromboplastinMice03 medical and health sciencesTissue factor0302 clinical medicineThrombinInternal medicinemedicineAnimalsHumansPlateletRats WistarEndothelial dysfunctionBlood CoagulationFactor XIAgedMice Knockoutbusiness.industryAngiotensin IIThrombinGeneral MedicineMiddle AgedOligonucleotides Antisensemedicine.diseaseAngiotensin IIMice Inbred C57BL030104 developmental biologyEndocrinologyBlood pressuremedicine.anatomical_structurePlatelet Glycoprotein GPIb-IX ComplexPathophysiology of hypertensionHypertensionFemalebusinessmedicine.drugBlood vesselScience Translational Medicine
researchProduct

Aliskiren: Just a New Drug for Few Selected Patients or an Innovative Molecule Predestinated to Replace Arbs and Ace-Inhibitors?

2009

The renin-angiotensin-aldosterone system (RAAS) plays a dominant role in the pathophysiology of hypertension, diabetes mellitus, chronic kidney disease and chronic heart failure. Therefore, drugs that block key components of the RAAS such as ACE inhibitors (ACEI) and angiotensin receptor blockers (ARBs) have gained wide clinical use for these indications. Despite progress, the morbidity and mortality of patients treated with ACEI or ARBs remain high. Aliskiren (Tekturna, Rasilez) is the first orally active inhibitor of renin approved for clinical use as an antihypertensive agent. The development program has established that at the licensed doses of 150 mg and 300 mg. Aliskiren is effective …

DrugACE inhibitorsmedia_common.quotation_subjectPharmaceutical Sciencelcsh:Medicinelcsh:RS1-441ReviewPharmacologylcsh:Pharmacy and materia medicachemistry.chemical_compoundRAS systemDiabetes mellitusDrug DiscoveryRenin–angiotensin systemmedicinecardiovascular diseasesmedia_commonbusiness.industrylcsh:RAliskirenmedicine.diseaseangiotensin receptor blockerschemistryPathophysiology of hypertensionHeart failureMolecular MedicineAngiotensin Receptor BlockersbusinessaliskirenKidney diseasePharmaceuticals
researchProduct

Markers of endothelial activation and left ventricular hypertrophy in essential hypertension

2003

Endothelial activationmedicine.medical_specialtybusiness.industryInternal medicinePathophysiology of hypertensionInternal MedicinemedicineCardiologymedicine.diseasebusinessLeft ventricular hypertrophyEssential hypertensionAmerican Journal of Hypertension
researchProduct

Influence of AT-1 receptor blockade on endothelium - derived factors in essential hypertension.

1999

Receptor blockademedicine.anatomical_structureEndotheliumbusiness.industryPathophysiology of hypertensionInternal MedicineMedicinePharmacologybusinessEssential hypertensionmedicine.diseaseAmerican Journal of Hypertension
researchProduct

The "Neurocentric" Approach to Essential Hypertension: How Reliable is the Paradigm of Hyperkinetic Hypertension? A Focus on the Sympathetic Nervous …

2017

BACKGROUND: Clinic resting heart rate (RHR), is one of the cardiovascular parameters more easily measurable. In the general population RHR has been associated with total and cardiovascular mortality and higher rate of vascular events. OBJECTIVE: The case of essential hypertension is in some ways peculiar: in the past decades has often been attributed to hypertensive subjects higher values of RHR than healthy controls as a result of the effects of the different factors leading to the development of essential hypertension itself, first of all the presence of an increased tone of the sympathetic nervous system Methods: Several excellent articles debated the issue of autonomic dysfunction in es…

Tachycardiaresting heart ratemedicine.medical_specialtySympathetic nervous systemRestPopulation030204 cardiovascular system & hematologyEssential hypertension03 medical and health sciences0302 clinical medicinehyperkinetic hypertensionHeart RateInternal medicineDrug DiscoveryHeart ratemedicineAnimalsHumans030212 general & internal medicineeducationPharmacologyeducation.field_of_studysympatho-vagal balancebusiness.industryessential hypertensionmedicine.diseaseBlood pressuremedicine.anatomical_structurePathophysiology of hypertensionAmbulatorySympathetic nervous systemCardiologymedicine.symptombusiness
researchProduct

Oxidative Stress, Inflammation and Endothelial Biomarkers in Arterial Hypertension

2008

business.industryPathophysiology of hypertensionImmunologyInternal MedicineMedicineInflammationmedicine.symptombusinessmedicine.diseasemedicine.disease_causeOxidative stressCurrent Hypertension Reviews
researchProduct

Hemorheological abnormalities in human arterial hypertension

2014

Blood rheology is impaired in hypertensive patients. The alteration involves blood and plasma viscosity, and the erythrocyte behaviour is often abnormal. The hemorheological pattern appears to be related to some pathophysiological mechanisms of hypertension and to organ damage, in particular left ventricular hypertrophy and myocardial ischemia. Abnormalities have been observed in erythrocyte membrane fluidity, explored by fluorescence spectroscopy and electron spin resonance. This may be relevant for red cell flow in microvessels and oxygen delivery to tissues. Although blood viscosity is not a direct target of antihypertensive therapy, the rheological properties of blood play a role in the…

erythrocyte deformabilitymedicine.medical_specialtySettore MED/09 - Medicina InternaRed Cellbusiness.industryerythrocyte membraneBlood viscosityessential hypertensionessential hypertension blood viscosity erythrocyte deformabilityCondensed Matter PhysicsEssential hypertensionmedicine.diseaseLeft ventricular hypertrophyPathophysiologyErythrocyte membraneInternal medicinePathophysiology of hypertensionblood viscositymedicineCardiologyErythrocyte deformabilityGeneral Materials SciencebusinessKorea-Australia Rheology Journal
researchProduct